BMC OPHTHALMOLOGY, cilt.20, sa.1, 2020 (SCI-Expanded)
Background: Systematically review the evidence describing the impact of anti-vascular endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular degeneration (nAMD) patient outcomes and healthcare resource utilization.